TABLE OF CONTENTS
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF MIDDLE EAST-AND AFRICA RICE PROTEIN BASED INFANT FORMULA MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 MIDDLE EAST-AND AFRICA RICE PROTEIN BASED INFANT FORMULA MARKET: GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.7 DBMR MARKET POSITION GRID
2.8 DBMR VENDOR SHARE ANALYSIS
2.9 MULTIVARIATE MODELING
2.10 PRODUCTS LIFELINE CURVE
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 MARKET OVERVIEW
3.1 DRIVERS
3.1.1 RISING POPULATION OF WORKING MOTHERS
3.1.2 GROWING INFANT POPULATION
3.1.3 INCREASING CASES OF BREAST CANCER
3.1.4 RICE PROTEIN BASED INFANT FORMULA IS WIDELY ACCEPTED AS NON-ALLERGIC PRODUCT
3.2 RESTRAINT
3.2.1 STRINGENT REGULATION
3.3 OPPORTUNITIES
3.3.1 GROWING ECONOMIES AND DISPOSABLE INCOME IN EMERGING REGIONS
3.3.2 INCREASING AWARENESS REGARDING IMPORTANCE OF NUTRITION FOR INFANTS
3.4 CHALLENGES
3.4.1 HIGH CONTENT OF TOXIC CHEMICALS IN RICE PROTEIN BASED INFANT FORMULA
3.4.2 IMPROPER PACKAGING OF BABY FOOD
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
6 MIDDLE EAST-AND AFRICA RICE PROTEIN BASED INFANT FORMULA MARKET, BY PRODUCT TYPE
6.1 OVERVIEW
6.2 FOLLOW-ON FORMULA
6.3 TODDLER FORMULA
6.4 STANDARD FORMULA
6.5 SPECIAL FORMULA
7 MIDDLE EAST-AND AFRICA RICE PROTEIN BASED INFANT FORMULA MARKET, BY TYPE
7.1 OVERVIEW
7.2 UNFORMULATED
7.3 FORMULATED
7.3.1 VEGETABLES
7.3.2 FRUITS
7.3.3 CEREAL
8 MIDDLE EAST-AND AFRICA RICE PROTEIN BASED INFANT FORMULA MARKET, BY FORM
8.1 OVERVIEW
8.2 NON-GMO
8.3 GMO
9 MIDDLE EAST-AND AFRICA RICE PROTEIN BASED INFANT FORMULA MARKET, BY INFANT AGE
9.1 OVERVIEW
9.2 6-12 MONTHS
9.3 1-3 YEARS
9.4 0-6 MONTHS
10 MIDDLE EAST-AND AFRICA RICE PROTEIN BASED INFANT FORMULA MARKET, BY DISTRIBUTION CHANNEL
10.1 OVERVIEW
10.2 STORE-BASED RETAILER
10.2.1 CONVENIENCE STORES
10.2.2 SUPERMARKETS/HYPERMARKETS
10.2.3 SPECIALTY STORES
10.2.4 GROCERY STORES
10.2.5 WHOLESALERS
10.3 NON-STORE RETAILER
10.3.1 ONLINE
10.3.2 VENDING
11 MIDDLE EAST-AND AFRICA RICE PROTEIN BASED INFANT FORMULA MARKET, BY GEOGRAPHY
11.1 MIDDLE EAST & AFRICA
11.1.1 SOUTH AFRICA
11.1.2 SAUDI ARABIA
11.1.3 UAE
11.1.4 KUWAIT
11.1.5 OMAN
11.1.6 QATAR
11.1.7 REST OF MIDDLE EAST & AFRICA
12 SWOT & DBMR ANALYSIS
12.1 SWOT ANALYSIS
12.2 DATA BRIDGE MARKET RESEARCH ANALYSIS
13 MIDDLE EAST-AND AFRICA RICE PROTEIN BASED INFANT FORMULA MARKET, COMPANY LANDSCAPE
13.1 COMPANY SHARE ANALYSIS: MIDDLE EAST & AFRICA
14 COMPANY PROFILE
14.1 LACTALIS INTERNATIONAL
14.1.1 COMPANY SNAPSHOT
14.1.2 COMPANY SHARE ANALYSIS
14.1.3 PRODUCT PORTFOLIO
14.1.4 RECENT DEVELOPMENTS
14.2 NOVALAC
14.2.1 COMPANY SNAPSHOT
14.2.2 COMPANY SHARE ANALYSIS
14.2.3 PRODUCT PORTFOLIO
14.2.4 RECENT DEVELOPMENT
14.3 BAYER AG
14.3.1 COMPANY SNAPSHOT
14.3.2 REVENUE ANALYSIS
14.3.3 COMPANY SHARE ANALYSIS
14.3.4 PRODUCT PORTFOLIO
14.3.5 RECENT DEVELOPMENT
14.4 LABORATORIOS ORDESA
14.4.1 COMPANY SNAPSHOT
14.4.2 COMPANY SHARE ANALYSIS
14.4.3 PRODUCT PORTFOLIO
14.4.4 RECENT DEVELOPMENT
14.5 BIOLAB PHARMA
14.5.1 COMPANY SNAPSHOT
14.5.2 PRODUCT PORTFOLIO
14.5.3 RECENT DEVELOPMENT
14.6 KATE FARMS
14.6.1 COMPANY SNAPSHOT
14.6.2 PRODUCT PORTFOLIO
14.6.3 RECENT DEVELOPMENT
14.7 LA MANDORLE
14.7.1 COMPANY SNAPSHOT
14.7.2 PRODUCT PORTFOLIO
14.7.3 RECENT DEVELOPMENT
14.8 NUCITEC SA DE CV
14.8.1 COMPANY SNAPSHOT
14.8.2 PRODUCT PORTFOLIO
14.8.3 RECENT DEVELOPMENT
15 QUESTIONNAIRE
16 CONCLUSION
17 RELATED REPORTS